Congenital Heart Defects: Could the Developing Heart Hold the Key to New Therapies?

submitted by: mcgheek

Andrew M. Atz, M.D., Chief of the Division of Pediatric Cardiology at MUSC's Children's Hospital, and Kyu-Ho Lee, M.D., PhD, a developmental biologist at MUSC's Cardiovascular Developmental Biology Center, discuss how better understanding the gene signaling involved in the embryonic development of the heart could lead to new adjunctive therapies for congenital heart defects. Learn more about Dr. Lee's work in the November 2013 issue of Progressnotes at

Integrative treatment for cancer and heart disease

submitted by: mdanderson
Download from itunes: MD Anderson Cancer Center’s Cardiology department is recognized nationally and internationally for its aggressive heart disease therapies not readily available in most communities. Jean-Bernard Durand, M.D., associate professor in Cardiology at MD Anderson, discusses how MD Anderson treats cancer patients with pre-existing heart disease, heart conditions that develop while undergoing cancer...

Updates on Consequences and Management of Obstructive Sleep Apnea

submitted by: mcgheekkm
Description: Dr. John Park, Assistant Professor of Medicine in the Division of Pulmonary and Critical Care and Sleep Medicine, in Rochester, MN, discusses his article appearing in the June 2011 issue of Mayo Clinic Proceedings which defines obstructive sleep apnea and updates the reader on consequences of the condition when left untreated and provides new strategies for its management. Available at: